Published

Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic Circuits

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Human Brain Mapping
Date: 2026-07-01
Source: Crossref
DOI: 10.1002/hbm.70596
PubMed: 42381187

Authors

Pasquini Lorenzo Vohryzek Jakub Escrichs Anira Perl Yonatan Sanz Ponce-Alvarez Adrian Idesis Sebastian Girn Manesh Roseman Leor Mitchell Jennifer M.Gazzaley Adam Kringelbach Morten Nutt David J.Lyons Taylor Carhart-Harris Robin L.Deco Gustavo

Watch author

Derived topics and classifications

psilocybin Depression Eating Disorders Brain Imaging Mechanism of Action Receptor Pharmacology Healthy Volunteers Other

Citation graph

40 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

10.1146/annurev.neuro.9.1.357 10.1016/j.bpsc.2022.04.003 10.1016/j.jneumeth.2013.10.018 10.1523/jneurosci.2830‐16.2016 10.1001/jamapsychiatry.2022.2096 10.1016/j.neuroimage.2017.03.045 10.1016/j.celrep.2018.05.022.psychedelics 10.1056/nejmoa2032994 10.1016/s2215‐0366(16)30065‐7 10.1073/pnas.1119598109 10.1124/pr.118.017160 10.1111/adb.12013

Indexed papers citing this DOI

Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic Circuits2026-07-01

Related papers

Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy VolunteersClinicalTrials.gov · 2026-02-05 Psilocybin Administration With 5-HT1a BlockadeClinicalTrials.gov · 2026-08-14 A Double Blind, Randomized Trial Investigating the Safety, Feasibility, and Mechanisms of Psychedelics in Healthy Older Adults With Low Well-being as Moderated by Biomarkers for Preclinical Alzheimer's DiseaseClinicalTrials.gov · 2026-06-08 Open Label Psilocybin Brain Stimulation and Imaging Pilot StudyClinicalTrials.gov · 2026-08-07 Multivariate Neural and Physiological Correlates of Psychedelic Sub-states: a Within-subjects, Healthy Volunteer Study With Experience-samplingClinicalTrials.gov · 2026-06-05 Investigation of Psychedelic Effects in Psychoactive SubstancesClinicalTrials.gov · 2026-02-23 A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of MLS101 (Psilocybin) in Healthy ParticipantsClinicalTrials.gov · 2025-06-12 A Phase 1 Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MLS101 (psilocybin) in Healthy ParticipantsClinicalTrials.gov · 2024-10-09